Cargando…

BH4 domain peptides derived from Bcl-2/Bcl-XL as novel tools against acute pancreatitis

Biliary acute pancreatitis (AP) is a serious condition, which currently has no specific treatment. Taurolithocholic acid 3-sulfate (TLC-S) is one of the most potent bile acids causing cytosolic Ca(2+) overload in pancreatic acinar cells (PACs), which results in premature activation of digestive enzy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vervliet, Tim, Gerasimenko, Julia V., Ferdek, Pawel E., Jakubowska, Monika A., Petersen, Ole H., Gerasimenko, Oleg V., Bultynck, Geert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945673/ https://www.ncbi.nlm.nih.gov/pubmed/29760956 http://dx.doi.org/10.1038/s41420-018-0054-5

Ejemplares similares

ABT‐199 (Venetoclax), a BH3‐mimetic Bcl‐2 inhibitor, does not cause Ca(2+)‐signalling dysregulation or toxicity in pancreatic acinar cells
por: Jakubowska, Monika A, et al.
Publicado: (2018)

BH3 mimetic-elicited Ca(2+) signals in pancreatic acinar cells are dependent on Bax and can be reduced by Ca(2+)-like peptides
por: Ferdek, Pawel E, et al.
Publicado: (2017)

A Novel Role for Bcl-2 in Regulation of Cellular Calcium Extrusion
por: Ferdek, Pawel E., et al.
Publicado: (2012)

Selective regulation of IP(3)-receptor-mediated Ca(2+) signaling and apoptosis by the BH4 domain of Bcl-2 versus Bcl-Xl
por: Monaco, G, et al.
Publicado: (2012)

Nitric oxide signals are interlinked with calcium signals in normal pancreatic stellate cells upon oxidative stress and inflammation
por: Jakubowska, Monika A., et al.
Publicado: (2016)

Bile acids induce necrosis in pancreatic stellate cells dependent on calcium entry and sodium‐driven bile uptake
por: Ferdek, Pawel E., et al.
Publicado: (2016)

Antagonizing Bcl-2′s BH4 domain in cancer
por: Vervloessem, Tamara, et al.
Publicado: (2015)

Inhibitors of Bcl-2 protein family deplete ER Ca(2+) stores in pancreatic acinar cells
por: Gerasimenko, Julia, et al.
Publicado: (2010)

Ryanodine receptors are targeted by anti-apoptotic Bcl-X(L) involving its BH4 domain and Lys87 from its BH3 domain
por: Vervliet, Tim, et al.
Publicado: (2015)

Activation of pancreatic stellate cells attenuates intracellular Ca(2+) signals due to downregulation of TRPA1 and protects against cell death induced by alcohol metabolites
por: Kusiak, Agnieszka A., et al.
Publicado: (2022)

TCTP contains a BH3-like domain, which instead of inhibiting, activates Bcl-xL
por: Thébault, Stéphanie, et al.
Publicado: (2016)

Alpha-Helical Destabilization of the Bcl-2-BH4-Domain Peptide Abolishes Its Ability to Inhibit the IP(3) Receptor
por: Monaco, Giovanni, et al.
Publicado: (2013)

The role of Ca(2+) in the pathophysiology of pancreatitis
por: Gerasimenko, Julia V, et al.
Publicado: (2014)

Pathobiology of acute pancreatitis: focus on intracellular calcium and calmodulin
por: Petersen, Ole H., et al.
Publicado: (2011)

Structural changes in the BH3 domain of SOUL protein upon interaction with the anti-apoptotic protein Bcl-xL
por: Ambrosi, Emmanuele, et al.
Publicado: (2011)

On BH3 Mimetics and Ca(2+) Signaling
por: Ferdek, Pawel E., et al.
Publicado: (2017)

Bim escapes displacement by BH3-mimetic anti-cancer drugs by double-bolt locking both Bcl-XL and Bcl-2
por: Liu, Qian, et al.
Publicado: (2019)

Calcium Signaling in Pancreatic Immune Cells In situ
por: Gryshchenko, Oleksiy, et al.
Publicado: (2020)

BDA-366, a putative Bcl-2 BH4 domain antagonist, induces apoptosis independently of Bcl-2 in a variety of cancer cell models
por: Vervloessem, Tamara, et al.
Publicado: (2020)

Structural and functional analyses of hepatitis B virus X protein BH3-like domain and Bcl-xL interaction
por: Zhang, Tian-Ying, et al.
Publicado: (2019)

SARS-CoV-2 S Protein Subunit 1 Elicits Ca(2+) Influx – Dependent Ca(2+) Signals in Pancreatic Stellate Cells and Macrophages In Situ
por: Gerasimenko, Julia V, et al.
Publicado: (2022)

Mutual Regulation of Bcl-2 Proteins Independent of the BH3 Domain as Shown by the BH3-Lacking Protein Bcl-x(AK)
por: Plötz, Michael, et al.
Publicado: (2012)

A novel BH3-mimetic, AZD0466, targeting BCL-XL and BCL-2 is effective in pre-clinical models of malignant pleural mesothelioma
por: Arulananda, Surein, et al.
Publicado: (2021)

Both RyRs and TPCs are required for NAADP-induced intracellular Ca(2+) release
por: Gerasimenko, Julia V., et al.
Publicado: (2015)

IP(3)R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP(3)R-derived peptide targeting the BH4 domain of Bcl-2
por: Akl, H, et al.
Publicado: (2013)

Ca(2+) signals mediated by bradykinin type 2 receptors in normal pancreatic stellate cells can be inhibited by specific Ca(2+) channel blockade
por: Gryshchenko, Oleksiy, et al.
Publicado: (2015)

LGG-11. BH3-MIMETICS TARGETING BCL-XL SELECTIVELY IMPACT THE SENESCENT COMPARTMENT OF PILOCYTIC ASTROCYTOMA
por: Selt, Florian, et al.
Publicado: (2021)

Directed elimination of senescent cells by inhibition of BCL-W and BCL-XL
por: Yosef, Reut, et al.
Publicado: (2016)

Bcl-XL but Not Bcl-2 Is a Potential Target in Medulloblastoma Therapy
por: Westhoff, Mike-Andrew, et al.
Publicado: (2022)

Bioinformatic Analysis of the BCL-xL/BCL2L1 Interactome in Patients with Pancreatic Cancer
por: Magouliotis, Dimitrios E., et al.
Publicado: (2022)

Bcl-xL in neuroprotection and plasticity
por: Jonas, Elizabeth A., et al.
Publicado: (2014)

DLBCL Cells with Acquired Resistance to Venetoclax Are Not Sensitized to BIRD-2 But Can Be Resensitized to Venetoclax through Bcl-XL Inhibition
por: Kerkhofs, Martijn, et al.
Publicado: (2020)

Prognostic significance of Bcl-xL expression and efficacy of Bcl-xL targeting therapy in urothelial carcinoma
por: Yoshimine, S, et al.
Publicado: (2013)

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma
por: Shebl, Bassem, et al.
Publicado: (2022)

Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
por: de Jong, Yvonne, et al.
Publicado: (2018)

Bcl-XL and Bcl-2 repress a common pathway of cell death
Publicado: (1995)

Targeting BCL-W and BCL-XL as a therapeutic strategy for Hodgkin lymphoma
por: Adams, Clare M., et al.
Publicado: (2019)

Combined inhibition of aurora kinases and Bcl-xL induces apoptosis through select BH3-only proteins
por: Li, Jian, et al.
Publicado: (2023)

CRAC channel inhibitors in pancreatic pathologies
por: Gerasimenko, Oleg V., et al.
Publicado: (2022)

Allosteric cross-talk between the hydrophobic cleft and the BH4 domain of Bcl-2 in control of inositol 1,4,5-trisphosphate receptor activity
por: Shapovalov, George, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3t21dug7qr0516vhe58205d0gb